Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60

1.

13N-ammonia PET/CT stress myocardial blood flow compared to fractional flow reserve in coronary artery disease.

Boer JJ, Kappelhof JJJS, van der Zant FM, Wondergem M, de Swart HJBRM, Knol RJJ.

Nucl Med Commun. 2019 Nov 15. doi: 10.1097/MNM.0000000000001117. [Epub ahead of print]

PMID:
31764595
2.

Lesion Detection and Interobserver Agreement with Advanced Image-Reconstructions for 18F-DCFPyL PET/CT in Patients with Biochemically Recurrent Prostate Cancer.

Jansen BHE, Jansen RW, Wondergem M, Srbljin S, de Klerk JMH, Lissenberg-Witte BI, Vis AN, van Moorselaar RJA, Boellaard R, Hoekstra OS, Oprea-Lager DE.

J Nucl Med. 2019 Sep 3. pii: jnumed.118.222513. doi: 10.2967/jnumed.118.222513. [Epub ahead of print]

PMID:
31481580
3.

Parathyroid imaging with 18F-fluorocholine PET/CT as a first-line imaging modality in primary hyperparathyroidism: a retrospective cohort study.

Broos WAM, Wondergem M, Knol RJJ, van der Zant FM.

EJNMMI Res. 2019 Jul 31;9(1):72. doi: 10.1186/s13550-019-0544-3.

4.

18F-DCFPyL Uptake in an Incidentally Detected Follicular Lymphoma by PET/CT Performed for Biochemically Recurrent Prostate Cancer.

Meijer D, Wondergem M, Knol RJJ, Broos WAM, van der Zant FM.

Clin Nucl Med. 2019 Jul 29. doi: 10.1097/RLU.0000000000002738. [Epub ahead of print]

PMID:
31361646
5.

18F-DCFPyL PET/CT in a Single Large Metastasis With Prostate-Specific Antigen Level of 856 ng/mL.

Wondergem M, Srbljin S, van der Zant FM, Broos WAM, Knol RJJ.

Clin Nucl Med. 2019 Oct;44(10):e588-e589. doi: 10.1097/RLU.0000000000002690.

PMID:
31274553
6.

Early lesion detection with 18F-DCFPyL PET/CT in 248 patients with biochemically recurrent prostate cancer.

Wondergem M, Jansen BHE, van der Zant FM, van der Sluis TM, Knol RJJ, van Kalmthout LWM, Hoekstra OS, van Moorselaar RJA, Oprea-Lager DE, Vis AN.

Eur J Nucl Med Mol Imaging. 2019 Aug;46(9):1911-1918. doi: 10.1007/s00259-019-04385-6. Epub 2019 Jun 22.

7.

Increased PSMA Expression in Castration-Resistant Prostate Cancer Metastases 3 Months After Initiation of Enzalutamide Indicated by 18F-DCFPyL PET/CT.

Wondergem M, van der Zant F, Broos W, Knol R.

Clin Nucl Med. 2019 Jul;44(7):582-584. doi: 10.1097/RLU.0000000000002585.

PMID:
31058686
8.

The non-erythroid myeloblast count rule in myelodysplastic syndromes: fruitful or futile?

van Spronsen MF, Westers TM, Lissenberg-Witte BI, Wondergem M, Ossenkoppele GJ, van de Loosdrecht AA.

Haematologica. 2019 Dec;104(12):e547-e550. doi: 10.3324/haematol.2018.212563. Epub 2019 Apr 19. No abstract available.

9.

Dual-Time-Point 18F-Fluorocholine PET/CT in Parathyroid Imaging.

Broos WAM, Wondergem M, van der Zant FM, Knol RJJ.

J Nucl Med. 2019 Nov;60(11):1605-1610. doi: 10.2967/jnumed.118.225599. Epub 2019 Mar 15.

PMID:
30877179
10.

Effect of forced diuresis during 18F-DCFPyL PET/CT in patients with prostate cancer: activity in ureters, kidneys and bladder and occurrence of halo artefacts around kidneys and bladder.

Wondergem M, van der Zant FM, Rafimanesh-Sadr L, Knol RJJ.

Nucl Med Commun. 2019 Jun;40(6):652-656. doi: 10.1097/MNM.0000000000001007.

PMID:
30855543
11.

Choline PET/CT in parathyroid imaging: a systematic review.

Broos WAM, van der Zant FM, Knol RJJ, Wondergem M.

Nucl Med Commun. 2019 Feb;40(2):96-105. doi: 10.1097/MNM.0000000000000952.

PMID:
30444749
12.

Tertiary Hyperparathyroidism With Renal Osteodystrophy on 18F-Fluorocholine PET/CT.

Broos WAM, Wondergem M, van der Zant FM, Knol RJJ.

Clin Nucl Med. 2018 Oct;43(10):766-768. doi: 10.1097/RLU.0000000000002230.

PMID:
30153138
13.

Rituximab and the risk of transformation of follicular lymphoma: a retrospective pooled analysis.

Federico M, Caballero Barrigón MD, Marcheselli L, Tarantino V, Manni M, Sarkozy C, Alonso-Álvarez S, Wondergem M, Cartron G, Lopez-Guillermo A, Issa D, Morschhauser F, Alcoceba M, Kimby E, Rusconi C, Chamuleau M, Holte H, Lockmer S, Montoto S, Gomes da Silva M, Aurer I, Zucca E, Paszkiewicz-Kozik E, Minoia C, Skrypets T, Blaker YN, Salles G, Coiffier B; Aristotle Consortium.

Lancet Haematol. 2018 Aug;5(8):e359-e367. doi: 10.1016/S2352-3026(18)30090-5. Epub 2018 Jul 4.

PMID:
30078408
14.
15.

Inactivated varicella zoster vaccine in autologous haemopoietic stem-cell transplant recipients: an international, multicentre, randomised, double-blind, placebo-controlled trial.

Winston DJ, Mullane KM, Cornely OA, Boeckh MJ, Brown JW, Pergam SA, Trociukas I, Žák P, Craig MD, Papanicolaou GA, Velez JD, Panse J, Hurtado K, Fernsler DA, Stek JE, Pang L, Su SC, Zhao Y, Chan ISF, Kaplan SS, Parrino J, Lee I, Popmihajlov Z, Annunziato PW, Arvin A; V212 Protocol 001 Trial Team.

Lancet. 2018 May 26;391(10135):2116-2127. doi: 10.1016/S0140-6736(18)30631-7. Epub 2018 May 24.

PMID:
29856344
16.

The European Hematology Curriculum: An Electronic Passport Promoting Professional Competence and Mobility.

Almeida AM, Ar C, Hellström-Lindberg E, Hollegien WWG, Navarro JT, Saris MT, Wondergem MJ, Toh CH.

Hemasphere. 2018 May 17;2(3):e49. doi: 10.1097/HS9.0000000000000049. eCollection 2018 Jun. Review. No abstract available.

17.

Effects of Fasting on 18F-DCFPyL Uptake in Prostate Cancer Lesions and Tissues with Known High Physiologic Uptake.

Wondergem M, van der Zant FM, Vlottes PW, Knol RJJ.

J Nucl Med. 2018 Jul;59(7):1081-1084. doi: 10.2967/jnumed.117.207316. Epub 2018 Mar 1.

18.

Time trend analysis of long term outcome of patients with haematological malignancies admitted at dutch intensive care units.

de Vries VA, Müller MCA, Sesmu Arbous M, Biemond BJ, Blijlevens NMA, Kusadasi N, Choi GCW, Vlaar APJ, van Westerloo DJ, Kluin-Nelemans HC, van den Bergh WM; HEMA-ICU Study Group.

Br J Haematol. 2018 Apr;181(1):68-76. doi: 10.1111/bjh.15140. Epub 2018 Feb 22.

PMID:
29468848
19.

Severe Secondary Polycythemia in a Female-to-Male Transgender Patient While Using Lifelong Hormonal Therapy: A Patient's Perspective.

Ederveen EGT, van Hunsel FPAM, Wondergem MJ, van Puijenbroek EP.

Drug Saf Case Rep. 2018 Feb 2;5(1):6. doi: 10.1007/s40800-018-0075-2.

20.

Incidental Detection of a Melanoma by 18F-Fluorocholine PET/CT Performed for Evaluation of Primary Hyperparathyroidism.

Burgers AMG, Wondergem M, van der Zant FM, Knol RJJ.

Clin Nucl Med. 2018 Apr;43(4):265-266. doi: 10.1097/RLU.0000000000001972.

PMID:
29356740
21.

Accuracy of 18F-NaF PET/CT in bone metastasis detection and its effect on patient management in patients with breast carcinoma.

Broos WAM, van der Zant FM, Wondergem M, Knol RJJ.

Nucl Med Commun. 2018 Apr;39(4):325-333. doi: 10.1097/MNM.0000000000000807.

PMID:
29351123
22.

Exercise Electrocardiogram Neither Predicts Nor Excludes Coronary Artery Disease in Women with Low to Intermediate Risk.

Knol RJJ, Kan H, Wondergem M, Cornel JH, Umans VAWM, van der Ploeg T, van der Zant FM.

J Womens Health (Larchmt). 2018 Apr;27(4):476-484. doi: 10.1089/jwh.2017.6433. Epub 2018 Jan 3.

PMID:
29297745
23.

Cardiac Displacement During 13N-Ammonia Myocardial Perfusion PET/CT: Comparison Between Adenosine- and Regadenoson-Induced Stress.

Vleeming EJ, Lazarenko SV, van der Zant FM, Pan XB, Declerck JM, Wondergem M, Knol RJJ.

J Nucl Med Technol. 2018 Jun;46(2):114-122. doi: 10.2967/jnmt.117.199463. Epub 2017 Dec 22.

24.

Metastasized 18F-DCFPyL-Negative Prostatic Adenocarcinoma Without Neuroendocrine Differentiation.

Broos WAM, Kocken M, van der Zant FM, Knol RJJ, Wondergem M.

Clin Nucl Med. 2018 Feb;43(2):120-122. doi: 10.1097/RLU.0000000000001929.

PMID:
29261618
25.

99mTc-HDP bone scintigraphy and 18F-sodiumfluoride PET/CT in primary staging of patients with prostate cancer.

Wondergem M, van der Zant FM, Knol RJJ, Burgers AMG, Bos SD, de Jong IJ, Pruim J.

World J Urol. 2018 Jan;36(1):27-34. doi: 10.1007/s00345-017-2096-3. Epub 2017 Oct 17.

26.

High 18Fluor-DCFPyL Uptake in Adrenal Adenomas.

Peper JGK, Srbljin S, van der Zant FM, Knol RJJ, Wondergem M.

Clin Nucl Med. 2017 Nov;42(11):862-864. doi: 10.1097/RLU.0000000000001808.

PMID:
28825951
27.

Baseline and longitudinal variability of normal tissue uptake values of [18F]-fluorothymidine-PET images.

Cysouw MCF, Kramer GM, Frings V, De Langen AJ, Wondergem MJ, Kenny LM, Aboagye EO, Kobe C, Wolf J, Hoekstra OS, Boellaard R.

Nucl Med Biol. 2017 Aug;51:18-24. doi: 10.1016/j.nucmedbio.2017.05.002. Epub 2017 May 10.

28.

18F-DCFPyL PET/CT in the Detection of Prostate Cancer at 60 and 120 Minutes: Detection Rate, Image Quality, Activity Kinetics, and Biodistribution.

Wondergem M, van der Zant FM, Knol RJJ, Lazarenko SV, Pruim J, de Jong IJ.

J Nucl Med. 2017 Nov;58(11):1797-1804. doi: 10.2967/jnumed.117.192658. Epub 2017 Apr 27.

29.

Incidental extra-cardiac findings on 13N-ammonia myocardial perfusion PET/CT.

Kan H, van der Zant FM, Wondergem M, Knol RJJ.

J Nucl Cardiol. 2017 Dec;24(6):1860-1868. doi: 10.1007/s12350-017-0824-0. Epub 2017 Apr 7.

PMID:
28390039
30.

(18)F-fluoride-PET for dynamic in vivo monitoring of bone formation in multiple myeloma.

Regelink JC, Raijmakers PG, Bravenboer N, Milek R, Hoetjes NJ, de Kreuk AM, van Duin M, Wondergem MJ, Lips P, Sonneveld P, Zijlstra JM, Zweegman S.

EJNMMI Res. 2016 Dec;6(1):46. doi: 10.1186/s13550-016-0197-4. Epub 2016 May 31.

31.

Occurrence of typical perfusion defects attributed to jailed or occluded side branch after ramus descendens anterior stenting in a patient cohort referred for 13NH3 myocardial PET/CT.

Kan H, Knol RJ, Lazarenko SV, Wondergem M, van der Zant FM.

Nucl Med Commun. 2016 May;37(5):480-6. doi: 10.1097/MNM.0000000000000471.

PMID:
26741289
32.

Impact of fasting on (18)F-fluorocholine gastrointestinal uptake and detection of lymph node metastases in patients with prostate cancer.

Wondergem M, van der Zant FM, Knol RJ, Pruim J, de Jong IJ.

EJNMMI Res. 2016 Dec;6(1):2. doi: 10.1186/s13550-015-0159-2. Epub 2016 Jan 6.

33.

Multiparameter flow cytometry is instrumental to distinguish myelodysplastic syndromes from non-neoplastic cytopenias.

Cremers EMP, Westers TM, Alhan C, Cali C, Wondergem MJ, Poddighe PJ, Ossenkoppele GJ, van de Loosdrecht AA.

Eur J Cancer. 2016 Feb;54:49-56. doi: 10.1016/j.ejca.2015.11.013. Epub 2015 Dec 22.

PMID:
26720403
34.

Authors' Response to Vadvala, et al.

Knol RJ, Wondergem M, van der Zant FM.

J Womens Health (Larchmt). 2015 Dec;24(12):1051. doi: 10.1089/jwh.2015.29003.rkr. No abstract available.

PMID:
26653870
35.

Patients' satisfaction with facial prostheses.

Wondergem M, Lieben G, Bouman S, van den Brekel MW, Lohuis PJ.

Br J Oral Maxillofac Surg. 2016 May;54(4):394-9. doi: 10.1016/j.bjoms.2015.09.011. Epub 2015 Oct 21.

PMID:
26508540
36.

Ruling out coronary artery disease in women with atypical chest pain: results of calcium score combined with coronary computed tomography angiography and associated radiation exposure.

van der Zant FM, Wondergem M, Lazarenko SV, Geenen RW, Umans VA, Cornel JH, Knol RJ.

J Womens Health (Larchmt). 2015 Jul;24(7):550-6. doi: 10.1089/jwh.2014.4929. Epub 2015 Apr 8.

PMID:
25853801
37.

18F-FDG or 3'-deoxy-3'-18F-fluorothymidine to detect transformation of follicular lymphoma.

Wondergem MJ, Rizvi SN, Jauw Y, Hoekstra OS, Hoetjes N, van de Ven PM, Boellaard R, Chamuleau ME, Cillessen SA, Regelink JC, Zweegman S, Zijlstra JM.

J Nucl Med. 2015 Feb;56(2):216-21. doi: 10.2967/jnumed.114.149625. Epub 2015 Jan 15.

38.

Trends in incidence, treatment and survival of aggressive B-cell lymphoma in the Netherlands 1989-2010.

Issa DE, van de Schans SA, Chamuleau ME, Karim-Kos HE, Wondergem M, Huijgens PC, Coebergh JW, Zweegman S, Visser O.

Haematologica. 2015 Apr;100(4):525-33. doi: 10.3324/haematol.2014.107300. Epub 2014 Dec 15.

39.

Genomic amplification of MYC as double minutes in a patient with APL-like leukemia.

Poddighe PJ, Wessels H, Merle P, Westers M, Bhola S, Loonen A, Zweegman S, Ossenkoppele GJ, Wondergem MJ.

Mol Cytogenet. 2014 Oct 22;7(1):67. doi: 10.1186/s13039-014-0067-6. eCollection 2014.

40.

Autologous transplantation for transformed non-Hodgkin lymphoma using an yttrium-90 ibritumomab tiuxetan conditioning regimen.

Mei M, Wondergem MJ, Palmer JM, Shimoni A, Hasenkamp J, Tsai NC, Simpson J, Nademanee A, Raubitschek A, Forman SJ, Krishnan AY.

Biol Blood Marrow Transplant. 2014 Dec;20(12):2072-5. doi: 10.1016/j.bbmt.2014.07.028. Epub 2014 Jul 29.

41.

Application of serum natalizumab levels during plasma exchange in MS patients with progressive multifocal leukoencephalopathy.

Vennegoor A, Rispens T, Van Oosten BW, Wattjes MP, Wondergem MJ, Teunissen CE, Van der Kleij D, Uitdehaag BM, Polman CH, Killestein J.

Mult Scler. 2015 Apr;21(4):481-4. doi: 10.1177/1352458514541507. Epub 2014 Jul 30.

PMID:
25078275
42.

[A woman with shortness of breath and butterfly shaped cell nuclei].

Schindhelm RK, Berends JC, Wondergem MJ.

Ned Tijdschr Geneeskd. 2014;158(6):A6759. Dutch.

PMID:
24495371
43.

Allogeneic transplantation after reduced-intensity conditioning with fludarabine-CY for both indolent and aggressive lymphoid malignancies.

Wondergem MJ, Dijkstra FS, Visser OJ, Zweegman S, Ossenkoppele GJ, Witte BI, Janssen JJ.

Bone Marrow Transplant. 2014 Apr;49(4):513-8. doi: 10.1038/bmt.2013.221. Epub 2014 Jan 13.

PMID:
24419517
44.

18 F-fluorothymidine uptake in follicular lymphoma and error-prone DNA repair.

Wondergem MJ, Herrmann K, Syrbu S, Zijlstra JM, Hoetjes N, Hoekstra OS, Cillessen SA, Moesbergen LM, Buck AK, Vose JM, Juweid ME.

EJNMMI Res. 2014 Jan 8;4(1):3. doi: 10.1186/2191-219X-4-3.

45.

Reply: A clinical dosimetric perspective uncovers new evidence and offers new insight in favor of 99mTc-macroaggregated albumin for predictive dosimetry in 90Y resin microsphere radioembolization.

Lam MG, Wondergem M, Elschot M, Smits ML.

J Nucl Med. 2013 Dec;54(12):2192-3. doi: 10.2967/jnumed.113.132852. Epub 2013 Nov 6. No abstract available.

46.

A literature review of 18F-fluoride PET/CT and 18F-choline or 11C-choline PET/CT for detection of bone metastases in patients with prostate cancer.

Wondergem M, van der Zant FM, van der Ploeg T, Knol RJ.

Nucl Med Commun. 2013 Oct;34(10):935-45. doi: 10.1097/MNM.0b013e328364918a. Review.

PMID:
23903557
47.

99mTc-macroaggregated albumin poorly predicts the intrahepatic distribution of 90Y resin microspheres in hepatic radioembolization.

Wondergem M, Smits ML, Elschot M, de Jong HW, Verkooijen HM, van den Bosch MA, Nijsen JF, Lam MG.

J Nucl Med. 2013 Aug;54(8):1294-301. doi: 10.2967/jnumed.112.117614. Epub 2013 Jun 7.

48.

Evaluation of gastrectomy in patients with delayed gastric emptying after antireflux surgery or large hiatal hernia repair.

Gerritsen A, Furnée EJ, Gooszen HG, Wondergem M, Hazebroek EJ.

World J Surg. 2013 May;37(5):1065-71. doi: 10.1007/s00268-013-1953-5.

PMID:
23435677
49.

A patient with a prolonged activated partial thromboplastin time and a deep intracerebral haemorrhage.

Schindhelm RK, Wondergem MJ, Admiraal J, Nap G, Boekel ET, Hani L.

Case Rep Neurol. 2012 May;4(2):131-6. doi: 10.1159/000342193. Epub 2012 Aug 22.

50.

Breast cancer sentinel node scintigraphy: differences between imaging results 1 and 2 h after injection.

Wondergem M, Hobbelink MG, Witkamp AJ, van Hillegersberg R, de Keizer B.

Nucl Med Commun. 2012 Nov;33(11):1138-43.

PMID:
22863761

Supplemental Content

Loading ...
Support Center